| HAMLET BIOPHARMA AB |
| Schweden |
| Gesundheit |
| SE0015661152 / A3CMH3 |
| 7ZT (Frankfurt) |
| FRA:7ZT, ETR:7ZT, 7ZT:GR |
| - |
| https://hamletbiopharma.c.. |
|
Hamlet BioPharma AB (publ) engages in the development of drugs for the treatment and prevention of cancer in Sweden. It is developing HAMLET, a tumoricidal protein-lipid complex formed by two generally regarded as safe (GRAS) molecules found in human..
>Volltext.. |
| 111.42 Mio. EUR |
| 109.88 Mio. EUR |
| - |
| -4.48 Mio. EUR |
| -5.4 Mio. EUR |
| -0.03 EUR |
| - |
| 1.56 Mio. EUR |
| -4.06 Mio. EUR |
| 2.19 |
| - |
| -25.86% |
| - |
| - |
| - |
| - |
| HAMLET BIOPHARMA |
| 05.04.26 |
|